Division of Nephrology, Department of Medicine, University of Missouri-Columbia, Columbia, MO.
Am J Kidney Dis. 2017 Mar;69(3):461-472. doi: 10.1053/j.ajkd.2016.11.007. Epub 2017 Jan 19.
Peritoneal dialysis (PD) is an effective therapy for patients with end-stage kidney disease. Dialysis solutions containing physiologic concentrations of electrolytes and base, as well as glucose often at supraphysiologic concentrations, are infused into the peritoneal cavity for solute and water exchange, and the patient's own peritoneal membrane is used for dialysis. The peritoneal membrane is dominated by small pores, which allow transport of water and small-molecular-size solutes, including electrolytes, by way of both diffusion and convection. Through small pores, diffusion allows the movement of solutes from the high-concentration compartment to a lower-concentration region. Also, through small pores, water and solutes move together by convection in response to an osmotic force. The glucose in the dialysis solution generates osmotic force to drive convection. In addition to small pores, the peritoneal membrane contains a specialized water channel, aquaporin 1, which is also present in capillaries of the peritoneal membrane. These specialized water channels, which are upregulated by glucose, allow water transport without solute (free water) in response to the osmotic force induced by glucose in the PD solution. During a PD exchange, net loss or gain of electrolytes and base is determined by both their gradient between capillary blood and dialysis solution and the net ultrafiltration volume. Developing a PD prescription, including the amount of glucose used, and changing the prescription in response to dietary changes and/or loss of residual kidney function requires a sound understanding of the peritoneal physiology. The case studies presented here help solidify the basic elements of PD prescription and how the PD prescription should be altered in response to changing clinical situations.
腹膜透析(PD)是治疗终末期肾病患者的有效疗法。透析液中含有生理浓度的电解质和碱基,以及通常处于超生理浓度的葡萄糖,这些物质被注入腹腔以进行溶质和水交换,而患者自身的腹膜则用于透析。腹膜主要由小孔组成,这些小孔允许水和小分子溶质(包括电解质)通过扩散和对流进行传输。通过小孔,扩散允许溶质从高浓度区域向低浓度区域移动。此外,通过小孔,水和溶质在渗透压的作用下一起通过对流移动。透析液中的葡萄糖产生渗透压以驱动对流。除了小孔,腹膜还包含一种特殊的水通道,水通道蛋白 1,它也存在于腹膜的毛细血管中。这些特殊的水通道在葡萄糖的作用下被上调,允许在没有溶质(自由水)的情况下通过渗透压进行水的运输。在 PD 交换过程中,电解质和碱基的净得失取决于它们在毛细血管血液和透析液之间的梯度以及净超滤量。制定 PD 处方,包括使用的葡萄糖量,并根据饮食变化和/或残留肾功能的丧失来改变处方,需要对腹膜生理学有深入的了解。这里呈现的案例研究有助于巩固 PD 处方的基本要素以及如何根据不断变化的临床情况来改变 PD 处方。